0001493152-23-024175.txt : 20230711 0001493152-23-024175.hdr.sgml : 20230711 20230711090031 ACCESSION NUMBER: 0001493152-23-024175 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20230706 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230711 DATE AS OF CHANGE: 20230711 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CareCloud, Inc. CENTRAL INDEX KEY: 0001582982 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 223832302 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36529 FILM NUMBER: 231081275 BUSINESS ADDRESS: STREET 1: 7 CLYDE ROAD STREET 2: SOMERSET CITY: SOMERSET STATE: NJ ZIP: 08873 BUSINESS PHONE: 7328735133 MAIL ADDRESS: STREET 1: 7 CLYDE ROAD STREET 2: SOMERSET CITY: SOMERSET STATE: NJ ZIP: 08873 FORMER COMPANY: FORMER CONFORMED NAME: MTBC, Inc. DATE OF NAME CHANGE: 20190206 FORMER COMPANY: FORMER CONFORMED NAME: MEDICAL TRANSCRIPTION BILLING, CORP DATE OF NAME CHANGE: 20130731 8-K 1 form8-k.htm
0001582982 false 0001582982 2023-07-06 2023-07-06 0001582982 CCLD:CommonStockParValue0.001PerShareMember 2023-07-06 2023-07-06 0001582982 CCLD:Sec11SeriesCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember 2023-07-06 2023-07-06 0001582982 CCLD:Sec8.75SeriesBCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember 2023-07-06 2023-07-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 6, 2023

 

CARECLOUD, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-36529   22-3832302

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

7 Clyde Road, Somerset, New Jersey, 08873

(Address of principal executive offices, zip code)

 

(732) 873-5133

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001 per share   CCLD   Nasdaq Global Market
11% Series A Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share   CCLDP   Nasdaq Global Market
8.75% Series B Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share   CCLDO   Nasdaq Global Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Effective July 10, 2023, Larry Steenvoorden has been appointed Chief Financial Officer and Bill Korn will continue as Chief Strategy Officer and no longer also be Acting Chief Financial Officer.

 

Mr. Steenvoorden, 53, served as the Chief Financial Officer and Executive Vice President of Chembio Diagnostics, Inc., a Nasdaq-listed medical device, point-of-care company with $50 million of revenue and global operations, from January 2022 until he joined us. Prior to that, from December 2017 to December 2021, Mr. Steenvoorden served as Senior Director, Private Equity CFO Services, Financial Accounting and Advisory for Accordion Partners, a private equity-focused financial consulting and technology firm. From March 2016 to November 2017, Mr. Steenvoorden served as Chief Financial and Accounting Officer of Onyx Renewable Partners, LP, a national provider of clean energy and decarbonization solutions established by Blackstone Group, one of the largest global private equity managers investing in the energy sector. From January 2012 to February 2016, Mr. Steenvoorden served as Global Controller and Vice President, Business Planning and Controlling for Siemens Healthcare Diagnostics, a global healthcare medical device manufacturing business. From 1992 to 2011, Mr. Steenvoorden served in various controller, director and assurance roles with several companies and was responsible for corporate accounting and financial reporting. Mr. Steenvoorden has extensive experience in financial reporting, business services, information systems, accounting operations, and strategic planning. Mr. Steenvoorden is a Board Member of the University of Delaware Accounting Advisory Council and Student Mentor Program. Mr. Steenvoorden received his Bachelor of Science in Accounting from the University of Delaware and his Master of Business Administration in Finance from Rider University.

 

On July 6, 2023, the registrant entered into an executive employment agreement with Mr. Steenvoorden, with an effective date of July 10, 2023.

 

Mr. Steenvoorden’s annual base salary will be $350,000 (“Base Salary”). At the sole discretion of the Board of Directors, Mr. Steenvoorden’s employment agreement entitles him to an annual performance bonus based upon the achievement of objectives established by the CEO and the Board of Directors, with a target of up to 45% of the Base Salary (the “Annual Bonus”), payable in restricted stock units (“RSUs”) pursuant to which Mr. Steenvoorden may receive shares of the registrant’s Series B Preferred Stock, calculated at a price of $25.00 per share. The grant and issuance of the Annual Bonus RSUs shall be made in accordance with the registrant’s Amended and Restated Equity Incentive Plan. Upon termination, Mr. Steenvoorden may receive severance of up to 24 months of his salary and bonus.

 

Upon signing his employment agreement, Mr. Steenvoorden will receive (i) a sign-on bonus (the “Sign-On Bonus”) of RSUs pursuant to which Mr. Steenvoorden will receive a number of shares of the registrant’s common stock (“Common Stock RSUs”) equal to $50,000 divided by the volume weighted average price of the registrant’s common stock for the ten day period ending on July 10, 2023 (the “VWAP”), and (ii) a retention bonus (the “Retention Bonus”) pursuant to which he may receive a number of Common Stock RSUs equal to $180,000 divided by the VWAP. The Sign-On Bonus RSUs shall vest upon completion of 30 days of employment. The Retention Bonus RSUs will vest over a three-year period, and provided that Mr. Steenvoorden remains in the active employ or service of the registrant on the applicable vesting date, (i) one-third of the Retention Bonus RSUs shall vest on July 10, 2024, (ii) one-third of the Retention Bonus RSUs shall vest on July 10, 2025, and (iii) the remaining one-third of the Retention Bonus RSUs shall vest on July 10, 2026. The grants and issuances of the Sign-On Bonus RSUs and the Retention Bonus RSUs shall be made in accordance with the registrant’s Amended and Restated Equity Incentive Plan.

 

Mr. Steenvoorden will be eligible to participate in benefit plans and programs generally available to other similarly-situated employees of the registrant.

 

2

 

 

The effective date of Mr. Steenvoorden’s employment agreement is July 10, 2023. The initial term for his employment agreement expires on July 10, 2025. The term of the employment agreement automatically renews for additional one-year terms unless either the registrant or Mr. Steenvoorden elects to terminate the agreement by notice to the other party delivered at least ninety (90) days prior to the expiration of the initial or any renewal term.

 

There are no family relationships between Mr. Steenvoorden and any director or executive officer of the registrant. Mr. Steenvoorden has no direct or indirect material interest in any related party transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

 

The foregoing description of the registrant’s appointment of the Chief Financial Officer and the key provisions of the executive’s employment agreement and bonus does not purport to be complete and is qualified entirely by reference to the terms of the actual executive employment agreement and bonus agreement, copies of which are attached as exhibits to this Current Report on Form 8-K and incorporated herein by reference.

 

Item 7.01 Regulation FD Disclosure.

 

On July 11, 2023, the registrant issued a press release announcing the appointment of Mr. Steenvoorden as Chief Financial Officer.

 

A copy of the press release is furnished as Exhibit 99.1, and the information set forth therein is incorporated herein by reference.

 

The information furnished in this Item 7.01, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and is not incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
     
10.1   Larry Steenvoorden Executive Employment Agreement
     
10.2   Larry Steenvoorden Bonus Agreement
     
99.1   Press Release dated July 11, 2023
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

3

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  CareCloud, Inc.
   
Date: July 11, 2023 By: /s/ A. Hadi Chaudhry
    A. Hadi Chaudhry
    Chief Executive Officer

 

4

 

EX-10.1 2 ex10-1.htm

 

Exhibit 10.1

 

CARECLOUD, INC.

EXECUTIVE EMPLOYMENT AGREEMENT

 

This EMPLOYMENT AGREEMENT, dated as of the 6th day of July, 2023 is by and between CareCloud, Inc., a Delaware corporation (the “Company”) and Larry Steenvoorden (the “Executive”).

 

WHEREAS, the Executive possesses unique knowledge of finance, account, tax, and the general responsibilities of a Chief Financial Officer; and

 

WHEREAS, the Board of Directors of the Company (the “Board of Directors”) believes it to be in the best interests of the Company to ensure the Executive’s employment by the Company in the capacity and under the terms and conditions set forth herein.

 

NOW, THEREFORE, in consideration of the foregoing and the mutual promises and agreements hereinafter set forth, the Company and Executive agree as follows:

 

1. Effective Date. This Employment Agreement shall become effective as of July 10, 2023 (the “Effective Date”).

 

2. Employment. The Company hereby employs the Executive, and the Executive hereby accepts employment, all upon the terms and conditions herein set forth.

 

3. Duties. The Executive shall perform such management duties for the Company and its affiliates as may from time to time be assigned and which are consistent with the title of Chief Financial Officer. The Executive hereby promises to perform and discharge, well and faithfully, all duties of his position. If the Executive is elected as a director or officer of any affiliate of the Company, the Executive shall serve in such capacity or capacities without further compensation.

 

4. Extent of Services.

 

(a) The Executive shall devote their entire time, attention and energies to the business of the Company and shall not during the term of this Employment Agreement be engaged in any other business activity whether or not such business activity is pursued for gain, profit or other pecuniary advantage; but this shall not be construed as preventing the Executive from investing personal assets in businesses which do not compete with the Company in such form or manner as will not require any services on the part of the Executive in the operation of the affairs of the companies in which such investments are made and in which the Executive’s participation is solely that of an investor, nor shall this be construed as preventing the Executive from purchasing securities in any entity whose securities are regularly traded provided that such purchases shall not result in the Executive collectively owning beneficially at any time one percent (1%) or more of the equity securities of any entity engaged in a business competitive to that of the Company, without the express prior written consent of the Company.

 

(b) It shall not be a violation of this Agreement for the Executive to serve on corporate, civic or charitable boards, advisory boards or committees; or deliver lectures, fulfill speaking engagements or teach at educational institutions, so long as such activities, separately or in the aggregate, do not materially interfere with the performance of the Executive’s responsibilities as an employee of the Company in accordance with this Agreement.

 

5. Compensation.

 

(a) For services rendered under this Employment Agreement, the Company shall pay the Executive a salary determined annually by the Board of Directors (the “Base Salary”), payable (after deduction of applicable payroll taxes) in the same manner and on the same payroll schedule in which Company employees receive payment. The Executive’s Base Salary as of the Effective Date shall be $350,000. The Executive shall also be eligible for and participate in such fringe benefits as shall be generally provided to executives of the Company, including those under the CareCloud, Inc. Amended and Restated Equity Incentive Plan, which may be adopted, amended and modified from time to time during the term hereof by the Company.

 

   

 

 

(b) The Compensation Committee of the Board of Directors shall review the Executive’s compensation from time to time and effect such increases in the Base Salary as the Board of Directors, in its sole discretion, determines are merited, based upon the Executive’s performance and consistent with the Company’s compensation policies. At the conclusion of each fiscal year, the Executive shall be eligible for, and the Board of Directors in its sole discretion may award, an executive bonus based on the achievement of objectives established by the CEO and the Board of Directors in line with the rules of the Company’s bonus plan. Executive’s current target bonus is up to 45% of the Annual Base Salary payable in CareCloud 8.5% Series B Cumulative Redeemable Perpetual Preferred Stock (Nasdaq: CCLDO) Restricted Stock Units (“RSU”) calculated at a rate of one RSU share per twenty-five dollars ($25.00) of value, provided that, depending on performance and results, the Executive’s actual bonus may be higher or lower than the target bonus, as determined by the Board of Directors.

 

6. Paid Time Off. During the term of this Employment Agreement, the Executive shall be entitled to the number of paid days off in accordance with the Company’s customary paid time off policy.

 

7. Expenses. During the term of this Employment Agreement, the Company shall reimburse the Executive for all reasonable out-of-pocket expenses incurred by the Executive in connection with the business of the Company and in the performance of the Executive’s duties under this Employment Agreement upon the Executive’s presentation to the Company of an itemized accounting of such expenses with reasonable supporting data.

 

8. Term. The Executive’s employment under this Employment Agreement shall commence on the Effective Date and shall expire on the second-year anniversary date thereof. The term of employment shall automatically be extended for consecutive periods of one (1) year each unless notice of termination of employment is given by either party hereto at least ninety (90) days prior to the expiration of the initial or any renewal term, in which case, this Employment Agreement shall terminate at the end of such initial or renewal term, as the case may be. In the case of a renewal and unless otherwise agreed to in writing by the parties, the terms and conditions of this Employment Agreement shall apply to any renewals or extensions thereto. Notwithstanding the foregoing, the Company may, at its election, terminate the Executive’s employment hereunder as follows:

 

(i) Upon thirty (30) days’ notice if the Executive becomes physically or mentally incapacitated or is injured so that the Executive is unable to perform the services required of hereunder and such inability to perform continues for a period in excess of twenty-six (26) weeks and is continuing at the time of such notice; or

 

(ii) For “Cause” upon notice of such termination to the Executive. For purposes of this Employment Agreement, the Company shall have “Cause” to terminate its obligations hereunder upon (A) the reasonable determination by the Board of Directors that the Executive has repeatedly failed to substantially perform his duties hereunder (other than as a result of his incapacity due to physical or mental illness or injury), which failure amounts to a repeated and consistent neglect of the Executive’s duties hereunder, (B) the reasonable determination by the Board of Directors that the Executive materially fails or refuses to comply with any lawful regulation or policy of the Company, and fails to correct the non-compliance following written notice from the Company, (C) the reasonable determination by the Board of Directors that the Executive has engaged or is about to engage in conduct materially injurious to the Company, (D) the Executive’s having been convicted of a felony or a misdemeanor involving moral turpitude, (E) a material breach by the Executive of any of the other covenants or representations herein or any other agreement between Executive and the Company, or (F) fraud, theft, embezzlement or misappropriation of Company property or funds; or

 

(iii) Without Cause at any time upon notice of such termination to the Executive; or

 

Page 2 of 8
 

 

(iv) Without Cause within twelve months after a Change in Control. Change in Control for purposes of this Agreement, unless the Board of Directors determines otherwise, shall be deemed to have occurred at such time as: (A) any person (as the term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (the Exchange Act)) is or becomes the beneficial owner (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of voting securities of the Company representing more than 50% of the Company’s outstanding voting securities or rights to acquire such securities except for any voting securities issued or purchased under any employee benefit plan of the Company or its subsidiaries, (B) any sale, lease, exchange or other transfer (in one transaction or a series of transactions) of all or substantially all of the assets of the Company, (C) a plan of liquidation of the Company or an agreement for the sale or liquidation of the Company is approved and completed, or (D) the Board of Directors determines in its sole discretion that a Change in Control has occurred, whether or not any event described above has occurred or is contemplated; or

 

(v) Upon the death of the Executive.

 

In addition, the Executive shall have the right to terminate this Employment Agreement upon notice to the Company if, without the Executive’s consent, the Executive’s responsibilities and duties on the date hereof are materially reduced (a “Material Demotion”) and such Material Demotion continues for ten (10) business days after the date of notice to the Company. A Material Demotion shall be treated as a termination by the Company without Cause and the Executive shall be entitled to receive salary continuation pay as provided by, and subject to the terms and conditions of, subparagraph 9(c) below.

 

9. Payment Upon Termination.

 

(a) If this Employment Agreement is terminated pursuant to paragraph 8(i) above, the Executive shall receive disability pay from the date of such termination until the second anniversary of such termination at the rate of 50% of the Base Salary, reduced by applicable payroll taxes and further reduced by the amount received by the Executive during such period under any Company-maintained disability insurance policy or plan or under Social Security or similar laws. Such disability payments shall be paid periodically to the Executive as provided in paragraph 5(a) for the payment of salary.

 

(b) If the Employment Agreement is terminated pursuant to paragraph 8(ii) or 8(v) above, the Executive shall receive no salary continuation pay or severance pay.

 

(c) If this Employment Agreement is terminated pursuant to paragraph 8(iii) or 8(iv) above, or as a result of the Executive having terminated this Employment Agreement following a Material Demotion, the Executive shall receive salary continuation pay for the remainder of the contractual term, but not in any event for less than twenty-four months from the date of such termination (“Salary Continuation Period”), equal to the Executive’s most recent annual salary plus the Executive’s target bonus (as determined under the bonus plan last in effect for the Executive). In addition, the Company shall pay the premiums necessary to continue the Executive’s group health coverage for the Salary Continuation Period under the applicable provisions of the Consolidated Omnibus Budget Reconciliation Act (“COBRA”), provided the Executive elects to continue and remains eligible for those benefits under COBRA, and does not become eligible for health coverage through another employer during this period; provided, however, that the salary continuation payments, bonus and other benefits described in this paragraph 9(c) shall cease if the Executive shall, directly or indirectly, be in breach of the Executive’s obligations under paragraph 13 hereof. Such salary continuation payments (less applicable payroll taxes) shall be paid periodically to the Executive as provided in paragraph 5(a) for the payment of the Base Salary.

 

(d) If the Company shall decide not to renew this Employment Agreement, the Executive shall receive severance pay, for a period of twenty-four months following the date of expiration of the then-current term (“Severance Pay”), equal to the Executive’s most recent annual salary (excluding any and all executive bonus plan amounts). Such severance payments (less applicable payroll taxes) shall be paid periodically to the Executive as provided in paragraph 5(a) for the payment of the Base Salary. The Executive hereby agrees to make a smooth transition of responsibilities during the ninety (90) day period prior to expiration of the Employment Agreement and the Executive further agrees not to take any legal action against the Company related to said non-renewal and termination of employment.

 

Page 3 of 8
 

 

(e) During the Salary Continuation Period or Severance Period, the Executive shall be under no obligation to mitigate the costs to the Company of the salary continuation or severance payments, and no compensation that the Executive may receive from another employer during the salary continuation or severance period shall be offset against amounts owed to Executive hereunder. Notwithstanding the foregoing, in order to be entitled to the payments under paragraphs 9(c) and (d), Executive shall be required to execute and deliver (and not revoke) a release of all employment-related claims against the Company in a form attached hereto as Exhibit A.

 

10. Representations. The Executive hereby represents to the Company that (a) the Executive is legally entitled to enter into this Employment Agreement and to perform the services contemplated herein and is not bound under any employment or consulting agreement to render services to any third party, (b) the Executive has the full right, power and authority, subject to no rights of third parties, to grant to the Company the rights contemplated by paragraph 11 hereof, and (c) the Executive does not now have, nor within the last three years has had, any ownership interest in any business enterprise (other than interest in publicly traded companies where the Executive’s ownership does not exceed one percent (1%) or more of the equity capital of such companies) which is a customer of the Company, any of its subsidiaries, or from which the Company or any of its subsidiaries purchases any goods or services or to whom such Companies owe any financial obligations or are required or directed to make any payments.

 

11. Inventions. The Executive hereby sells, transfers and assigns to the Company or to any person or entity designated by the Company all of the entire right, title and interest of the Executive in and to all inventions, ideas, disclosures and improvements, whether patented or unpatented, and copyrightable material, made or conceived by the Executive, solely or jointly, during the term hereof which relate to methods, apparatus, designs, products, processes or devices, sold, leased, used or under consideration or development by the Company or any of its affiliates or which otherwise relate to or pertain to the business, functions or operations of the Company or any of its affiliates or which arise from the efforts of the Executive during the course of his employment for the Company or any of its affiliates. The Executive shall communicate promptly and disclose to the Company, in such form as the Company requests, all information, details and data pertaining to the aforementioned inventions, ideas, disclosures and improvements; and the Executive shall execute and deliver to the Company such formal transfers and assignments and such other papers and documents as may be necessary or required of the Executive to permit the Company or any person or entity designated by the Company to file and prosecute the patent applications and, as to copyrightable material, to obtain copyright thereof. Any invention relating to the business of the Company and its affiliates and disclosed by the Executive within one year following the termination of this Employment Agreement shall be deemed to fall within the provisions of this paragraph unless proved to have been first conceived and made following such termination.

 

12. Disclosure of Information. The Executive recognizes and acknowledges that the trade secrets, know-how and proprietary processes of the Company and its affiliates as they may exist from time to time are valuable, special and unique assets of the business of the Company and its affiliates, access to and knowledge of which are essential to the performance of the Executive’s duties hereunder. The Executive will not, during or after the term of the Executive’s employment by the Company or any of its affiliates, in whole or in part, disclose such secrets, know-how or processes to any person, firm, Company, association or other entity for any reason or purpose whatsoever, nor shall the Executive make use of any such property for the Executive’s own purposes or for the benefit of any person, firm, Company or other entity (except the Company and its affiliates) under any circumstances during or after the term of the Executive’s employment, provided that after the term of the Executive’s employment, these restrictions shall not apply to such secrets, know-how and processes which are then in the public domain (provided that the Executive was not responsible, directly or indirectly, for such secrets, know-how or processes entering the public domain without the Company’s consent).

 

Page 4 of 8
 

 

13. Non-Competition. During the term of the Executive’s employment hereunder and for a period beginning on the date of termination of the Executive’s employment hereunder for any reason and ending on the later of one (1) year after the date of this Agreement or one (1) year after any such termination of employment (“Non-Competition Period”), Executive shall not:

 

a) without the prior written consent of the Company, directly or indirectly, as an Executive, employer, agent, principal, proprietor, partner, stockholder, consultant, employee, director, or corporate officer, engage in any business or render any services to any business that is in competition with the business of the Company; and

 

b) (i) solicit any employee of the Company to engage in a competitive business or (ii) solicit customers of the Company on behalf of any company or entity whose business is competitive with the Company.

 

If the scope of any restrictions contained in Subsections (a) or (b) of this Section 13 are too broad to permit enforcement of such restrictions to their full extent, then such restrictions shall be enforced to the maximum extent permitted by law, and Executive hereby consents and agrees that such scope may be judicially modified accordingly in any proceeding brought to enforce such restrictions.

 

14. Injunctive Relief. If there is a breach or threatened breach of the provisions of paragraphs 11, 12 or 13 of this Employment Agreement, the Company shall be entitled to an injunction restraining the Executive from such breach. Nothing herein shall be construed as prohibiting the Company from pursuing any other remedies for such breach or threatened breach.

 

15. Insurance. The Company may, at its election and for its benefit, insure the Executive against accidental loss or death, and the Executive shall submit to such physical examination and supply such information as may be required in connection therewith.

 

16. Exit Obligations. Upon (a) the termination of the Executive’s employment or (b) the Company’s request at any time during the Executive’s employment, the Executive shall (i) provide or return to the Company any and all Company property and all Company documents and materials belonging to the Company and stored in any fashion, including, but not limited to those that constitute or contain any confidential information or work product, that are in the possession or control of the Executive, whether they were provided to the Executive by the Company or any of its business associates or created by the Executive in connection with the Executive’s employment by the Company; and (ii) delete or destroy all copies of any such documents and materials not returned to the Company that remain in the Executive’s possession or control, including those stored on any non-Company devices, networks, storage locations, and media in the Executive’s possession or control.

 

16. Notices. Any notice required or permitted to be given under this Employment Agreement shall be sufficient if in writing and if sent by registered mail to the Executive at his home address as reflected on the records of the Company, in the case of the Executive, or CareCloud, Inc., 7 Clyde Road, Somerset New Jersey 08873, in the case of the Company.

 

17. Waiver of Breach. A waiver by the Company or the Executive of a breach of any provision of this Employment Agreement by the other party shall not operate or be construed as a waiver of any subsequent breach by the other party.

 

18. Governing Law. This Employment Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New Jersey without giving effect to the choice of law or conflict of laws provisions thereof.

 

19. Assignment. This Employment Agreement may be assigned, without the consent of the Executive, by the Company to any of its affiliates, or to any other person, partnership, company, or other entity which has purchased substantially all the assets of the Company, provided such assignee assumes all the liabilities of the Company hereunder. This Employment Agreement is personal to the Executive and shall not be assigned by the Executive.

 

20. Severability. If any provision of any part of this Agreement is determined to be invalid or unenforceable, such invalidity or unenforceability shall not invalidate or render unenforceable any other portion of this Agreement. The entire Agreement shall be construed as if it did not contain the particular invalid or unenforceable provision(s) and the rights and obligations of the Parties shall be construed and enforced accordingly.

 

21. Entire Agreement. This Employment Agreement contains the entire agreement of the parties and supersedes any and all agreements, letter of intent or understandings between the Executive and (a) the Company, and (b) any of the Company’s principal shareholders, affiliates or subsidiaries regarding employment. This Employment Agreement may be changed only by an agreement in writing signed by a party against whom enforcement of any waiver, change, modification, extension or discharge is sought.

 

[Signature Page Follows]

 

Page 5 of 8
 

 

IN WITNESS WHEREOF, the parties have executed this Employment Agreement as of the day first herein above written.

 

EXECUTIVE

 

By: /s/ Larry Steenvoorden  
  Larry Steenvoorden  

 

Date: July 6, 2023

 

CARECLOUD, INC.

 

By: /s/ Kimberly Blanche  
  Kimberly Blanche  
  General Counsel  

 

Date: July 6, 2023

 

Page 6 of 8
 

 

EXHIBIT A

 

SEPARATION AGREEMENT AND RELEASE

 

I, ______________________________, hereby acknowledge that CareCloud, Inc. (“the Company”) has advised me by letter dated _____________________(“the Letter”) of the pay and benefits to which I am entitled in connection with the separation of my employment with the Company, and the separation pay which it has agreed to pay to me in exchange for my signing this Separation Agreement and Release (“Release”). I further hereby acknowledge that the Company has advised me that I have a period of forty-five (45) days from the date of such Letter to sign the Release, but that I may sign it before the forty-five (45) days expire. I also understand that I have a period of seven (7) days following the date of my signature on the Release to change my mind and cancel this Release by sending a written revocation notice to the attention of General Counsel, CareCloud, Inc., 7 Clyde Road, Somerset, NJ 08873. I understand that this Release is not enforceable until after the end of the seven (7) day period. I understand and agree that, should I revoke my Release, I will return any severance pay paid to me by the Company in exchange for signing the Release.

 

In consideration of such separation pay and other benefits as set forth above and in the Letter, to which I acknowledge I am not otherwise entitled, I hereby knowingly, freely, and voluntarily release the Company, the Company’s respective associates, affiliates, predecessors, successors, subsidiaries, parents, or agents of any of them, and the directors, officers, employees and agents of any of them, and shareholders (all the parties mentioned immediately before shall be referred to as the “Released Parties”) from, and waive any right to personal benefit arising from any proceedings or lawsuits, in connection with any and all claims relating to my employment, or the separation of my employment which I have or may have or acquire up to the date of my signature on this Release, including, but not limited to, claims of discrimination whether arising under Title VII of the Civil Rights Act of 1964, the Age Discrimination in Employment Act of 1967 as amended, the Older Workers Benefit Protection Act, the Rehabilitation Act of 1973, the Americans with Disabilities Act, the Civil Rights Act of 1991 or any other federal, state or local law. Moreover, I release all claims and waive all rights to file a judicial action and to receive personal benefit in connection with any other proceeding against the Released Parties arising from claims of breach of contract, claims for benefits other than those required by applicable law, claims for additional compensation and/or commissions, claims that the separation of my employment was wrongful, unjust or a violation of public policy or any other claim arising out of any matter concerning the Company or Released Parties in any form which may have occurred prior to the date of my signature on this Release. Notwithstanding the foregoing, this Release does not waive or release any claims that cannot be legally waived or released as a matter of law, such as filing a claim for unemployment insurance benefits. This Release also does not prevent me from filing a charge or complaint with, communicating with, or participating in an investigation or proceeding conducted by the Equal Employment Opportunity Commission (EEOC), the Securities and Exchange Commission (SEC), the National Labor Relations Board (NLRB), or any other federal, state, or local governmental agency or commission (“Government Agencies”). However, to the fullest extent permitted by law, I agree that I am waiving the right to monetary damages or other equitable or monetary relief as a result of any charge, complaint, investigation, or proceeding with those Government Agencies.

 

I agree that I will not, directly or indirectly, engage in any conduct or make any statement disparaging or criticizing in any way the Company or any of its subsidiaries or affiliates or any of their respective officers, directors or employees nor shall I, directly or indirectly, engage in any conduct or make any statement that could be reasonably expected to impair the goodwill or reputation of the Company or any of its subsidiaries or affiliates, in each case, except to the extent required by law, and then only after consultation with the Company to the extent possible. However, nothing in this paragraph shall in any way require me to conceal any details relating to a claim of discrimination, retaliation, or harassment under any applicable law of discrimination, even though such claim is released. In addition, nothing contained in this paragraph shall or is intended to preclude me from testifying truthfully pursuant to any government or regulatory investigation or pursuant to subpoena or other court order. I understand that I retain the right to communicate with the Government Agencies and such communication can be initiated by me or in response to the government and is not limited by any non-disparagement obligation herein. The Company agrees it will use its reasonable efforts to ensure that the Company does not, directly or indirectly, engage in any conduct or make any statement disparaging or criticizing me in any way, or engage in any other conduct or make any other statement that could be reasonably expected to impair my business reputation, except to the extent required by law, and then only after consultation with me to the extent possible; provided, that any refusal by the Company to give a reference shall not be a breach of this provision.

 

I recognize that this Release shall be binding upon and apply to all of my heirs, executors, administrators, successors and assigns. In the event that state law restricts general releases and provides me with statutory rights, I also waive my right to such statutory protection to the full extent lawfully possible. This Release shall run to and benefit the Company and its respective associates, affiliates, predecessors, successors, subsidiaries, parents, or agents of any of them, assigns and the past and present directors, officers, agents, and employees.

 

[Signature page follows]

 

Page 7 of 8
 

 

I agree that the Company has advised me in writing of my right to consult with an attorney of my choice prior to signing this Release and has provided me with sufficient time to review and sign the Release. I have carefully read and fully understand the contents of the Release and my voluntary signature is evidence of my intent to be legally bound by its terms.

 

     
(Print or Type Name)   (Witness Name - Printed or Typed)
     
     
Signature   Witness Signature
     
 Date_______________________________________    Date___________________________________

 

Page 8 of 8

 

EX-10.2 3 ex10-2.htm

 

Exhibit 10.2

 

CARECLOUD, INC.

BONUS AGREEMENT

 

This BONUS AGREEMENT (the “Agreement”), dated as of the 6th day of July, 2023 is by and between CareCloud, Inc., a Delaware corporation (the “Company”) and Larry Steenvoorden (the “Executive”).

 

WHEREAS, the Company and Executive entered into an Executive Employment Agreement (“Employment Agreement”), whereby the Executive was employed as the Chief Financial Officer of the Company effective as of July 10, 2023; and

 

WHEREAS, the Board of Directors of the Company believes it to be in the best interests of the Company to incentivize the Executive’s employment with the Company by offering a sign-on bonus and a retention bonus under the terms and conditions set forth herein.

 

NOW, THEREFORE, in consideration of the foregoing and the mutual promises and agreements hereinafter set forth, the Company and Executive agree as follows:

 

1. Sign-On Bonus. As soon as reasonably practicable after the date of this Agreement, Company shall grant to the Executive a one-time sign-on bonus (the “Sign-On Bonus”) of a number of restricted stock units (“RSUs”) equal to $50,000 divided by the VWAP (such RSUs shall be rounded up or down, as the case may be, to the nearest whole number), which will entitle the Executive to receive one share of common stock of the Company (“Common Stock”) for each RSU upon its vesting. The Sign-On Bonus RSUs shall vest upon Executive’s successful completion of thirty (30) days of employment with the Company.

 

2. Retention Bonus. As soon as reasonably practicable after the date of this Agreement, the Company shall grant to the Executive a retention bonus (the “Retention Bonus”) of a number of RSUs equal to $180,000 divided by the VWAP (such RSUs shall be rounded up or down, as the case may be, to the nearest whole number), which will entitle the Executive to receive one share of Common Stock for each RSU upon its vesting. Provided that the Executive remains in the active employ or service of the Company or any of its subsidiaries through each vesting date, (i) one-third of the Retention Bonus RSUs shall vest on July 10, 2024, (ii) one-third of the Retention Bonus RSUs shall vest on July 10, 2025, and (ii) the remaining one-third of the Retention Bonus RSUs shall vest on July 10, 2026.

 

3. VWAP. For purposes of this Agreement, “VWAP” shall mean the volume weighted average price per share of Common Stock on the Nasdaq Global Market as reported by, or based upon data reported by, Bloomberg Financial Markets or an equivalent, reliable reporting service selected by the Company, in respect of the period from the scheduled open of trading until the scheduled close of trading of the primary trading session for the 10-day period ending on July 10, 2023. The VWAP will be determined without regard to after-hours trading or any other trading outside of the primary trading session on such dates. If the VWAP cannot be calculated for shares of Common Stock on the foregoing basis, the VWAP of a share of Common Stock for the aforementioned period shall be as determined in good faith by the Board of Directors of the Company.

 

4. Equity Incentive Plan and Award Agreement. The grants and issuances of the Sign-On Bonus RSUs and the Retention Bonus RSUs shall be made in accordance with the Company’s Amended and Restated Equity Incentive Plan (“Plan”) and pursuant to a Restricted Stock Unit Award Agreement between the Company and the Executive (“RSU Award Agreement”). In the event of a conflict between the terms of this Agreement and the terms of the Plan and RSU Award Agreement, the terms of the Plan and RSU Award Agreement shall control.

 

5. No Continued Employment. Nothing in this Agreement, the Plan or the RSU Award Agreement shall confer upon Executive any right to be retained in the service of, or continue to be affiliated with, the Company or any subsidiary, nor does it interfere in any way with the right of the Company to terminate Executive’s employment in accordance with the Employment Agreement.

 

 

 

 

6. Notices. Any notice required or permitted to be given under this Agreement shall be sufficient if in writing and if sent by registered mail to the Executive at his home address as reflected on the records of the Company, in the case of the Executive, or CareCloud, Inc., 7 Clyde Road, Somerset New Jersey 08873, in the case of the Company.

 

7. Waiver of Breach. A waiver by the Company or the Executive of a breach of any provision of this Agreement by the other party shall not operate or be construed as a waiver of any subsequent breach by the other party.

 

8. Governing Law. This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New Jersey without giving effect to the choice of law or conflict of laws provisions thereof.

 

9. Assignment. This Agreement may be assigned, without the consent of the Executive, by the Company to any of its affiliates, or to any other person, partnership, company, or other entity which has purchased substantially all the assets of the Company, provided such assignee assumes all the liabilities of the Company hereunder. This Agreement is personal to the Executive and shall not be assigned by the Executive.

 

10. Severability. If any provision of any part of this Agreement is determined to be invalid or unenforceable, such invalidity or unenforceability shall not invalidate or render unenforceable any other portion of this Agreement. The entire Agreement shall be construed as if it did not contain the particular invalid or unenforceable provision(s) and the rights and obligations of the parties shall be construed and enforced accordingly.

 

11. Entire Agreement. This Agreement contains the entire agreement of the parties as to the matters herein, and supersedes any and all agreements, letter of intent or understandings between the Executive and the Company as to same. This Agreement may be changed only by an agreement in writing signed by a party against whom enforcement of any waiver, change, modification, extension or discharge is sought.

 

[Signature page follows]

 

 

 

 

IN WITNESS WHEREOF, the parties have executed this Agreement as of the day first herein above written.

 

EXECUTIVE  
     
By: /s/ Larry Steenvoorden  
  Larry Steenvoorden  
     
Date: July 6, 2023  

 

CARECLOUD, INC.  
     
By: /s/ Kimberly Blanche  
  Kimberly Blanche  
  General Counsel  
     
Date: July 6, 2023  

 

 

 

EX-99.1 4 ex99-1.htm

 

Exhibit 99.1

 

 

CareCloud Appoints Larry Steenvoorden as Chief Financial Officer

 

SOMERSET, N.J., JULY 11, 2023 (GLOBE NEWSWIRE) — CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced the appointment of Larry Steenvoorden as the new chief financial officer (CFO). With a distinguished career and extensive financial and strategic expertise, Steenvoorden brings valuable experience from his previous roles.

 

Before joining CareCloud, he served as the executive vice president and CFO at Chembio Diagnostics, where he implemented strategic initiatives and improved profitability. Steenvoorden has also held CFO positions in healthcare, life science, and med-tech companies, providing him with a deep understanding of the unique challenges in the healthcare technology space.

 

Prior to his industry roles, Steenvoorden held key positions at Siemens AG, including global controller and vice president of business planning and controlling for Siemens Healthcare Diagnostics. He is a certified public accountant with a Bachelor of Science degree in accounting from the University of Delaware and a Master of Business Administration degree from Rider University.

 

As CareCloud’s new CFO, Steenvoorden will play a vital role in the company’s financial strategy and growth initiatives. His expertise and track record make him an invaluable addition to the executive team, and his appointment comes at a time when CareCloud is expanding its presence in the healthcare technology market.

 

“We are thrilled to welcome Larry to CareCloud as our new CFO,” said Bill Korn, CareCloud’s former CFO who assumed the role of chief strategy officer in May 2023. “His exceptional financial expertise and industry knowledge will strengthen our financial position and support our mission to revolutionize the healthcare technology landscape. With Larry’s guidance, we’ll continue driving innovation and delivering unparalleled value to our customers.”

 

“Larry’s diverse skill set and dedication to breaking barriers will propel our team to unprecedented success,” added Hadi Chaudhry, chief executive officer and president of CareCloud. “With his fresh ideas and profound expertise, we are poised to achieve extraordinary accomplishments, transforming possibilities into realities.”

 

To learn more about how CareCloud is redefining the next generation of technology-enabled revenue cycle solutions, visit carecloud.com.

 

About CareCloud

 

CareCloud (Nasdaq: CCLD, CCLDP, CCLDO) brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at www.carecloud.com.

 

Follow CareCloud on LinkedIn, Twitter and Facebook.

 

SOURCE CareCloud

 

Company Contact:

 

Bill Korn

Chief Strategy Officer

CareCloud

bkorn@carecloud.com

 

Investor Contact:

 

Asher Dewhurst

ICR Westwicke

CareCloudIR@westwicke.com

 

Media Inquiries:

 

Alexis Feinberg

ICR Westwicke

CareCloudPR@westwicke.com

 

 

 

GRAPHIC 5 ex99-1_001.jpg begin 644 ex99-1_001.jpg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end EX-101.SCH 6 ccld-20230706.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 7 ccld-20230706_def.xml XBRL DEFINITION FILE EX-101.LAB 8 ccld-20230706_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock, par value $0.001 per share 11% Series A Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 9 ccld-20230706_pre.xml XBRL PRESENTATION FILE XML 10 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover
Jul. 06, 2023
Document Type 8-K
Amendment Flag false
Document Period End Date Jul. 06, 2023
Entity File Number 001-36529
Entity Registrant Name CARECLOUD, INC.
Entity Central Index Key 0001582982
Entity Tax Identification Number 22-3832302
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 7 Clyde Road
Entity Address, City or Town Somerset
Entity Address, State or Province NJ
Entity Address, Postal Zip Code 08873
City Area Code (732)
Local Phone Number 873-5133
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Common Stock, par value $0.001 per share  
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol CCLD
Security Exchange Name NASDAQ
11% Series A Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share  
Title of 12(b) Security 11% Series A Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share
Trading Symbol CCLDP
Security Exchange Name NASDAQ
8.75% Series B Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share  
Title of 12(b) Security 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share
Trading Symbol CCLDO
Security Exchange Name NASDAQ
XML 11 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001582982 2023-07-06 2023-07-06 0001582982 CCLD:CommonStockParValue0.001PerShareMember 2023-07-06 2023-07-06 0001582982 CCLD:Sec11SeriesCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember 2023-07-06 2023-07-06 0001582982 CCLD:Sec8.75SeriesBCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember 2023-07-06 2023-07-06 iso4217:USD shares iso4217:USD shares 0001582982 false 8-K 2023-07-06 CARECLOUD, INC. DE 001-36529 22-3832302 7 Clyde Road Somerset NJ 08873 (732) 873-5133 false false false false Common Stock, par value $0.001 per share CCLD NASDAQ 11% Series A Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share CCLDP NASDAQ 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share CCLDO NASDAQ false EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 13 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 4 22 1 false 3 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://carecloud.com/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm ccld-20230706.xsd ccld-20230706_def.xml ccld-20230706_lab.xml ccld-20230706_pre.xml ex10-1.htm ex10-2.htm ex99-1.htm http://xbrl.sec.gov/dei/2023 true false JSON 17 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form8-k.htm": { "axisCustom": 0, "axisStandard": 1, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 28 }, "contextCount": 4, "dts": { "definitionLink": { "local": [ "ccld-20230706_def.xml" ] }, "inline": { "local": [ "form8-k.htm" ] }, "labelLink": { "local": [ "ccld-20230706_lab.xml" ] }, "presentationLink": { "local": [ "ccld-20230706_pre.xml" ] }, "schema": { "local": [ "ccld-20230706.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 66, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 3, "memberStandard": 0, "nsprefix": "CCLD", "nsuri": "http://carecloud.com/20230706", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form8-k.htm", "contextRef": "AsOf2023-07-06", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://carecloud.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form8-k.htm", "contextRef": "AsOf2023-07-06", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 3, "tag": { "CCLD_CommonStockParValue0.001PerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock, par value $0.001 per share" } } }, "localname": "CommonStockParValue0.001PerShareMember", "nsuri": "http://carecloud.com/20230706", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "domainItemType" }, "CCLD_Sec11SeriesCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "11% Series A Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share" } } }, "localname": "Sec11SeriesCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember", "nsuri": "http://carecloud.com/20230706", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "domainItemType" }, "CCLD_Sec8.75SeriesBCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "8.75% Series B Cumulative Redeemable Perpetual Preferred Stock, par value $0.001 per share" } } }, "localname": "Sec8.75SeriesBCumulativeRedeemablePerpetualPreferredStockParValue0.001PerShareMember", "nsuri": "http://carecloud.com/20230706", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2023", "presentation": [ "http://carecloud.com/role/Cover" ], "xbrltype": "stringItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 18 0001493152-23-024175-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-024175-xbrl.zip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end